nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—CHRNA2—nervous system—Gilles de la Tourette syndrome	0.0328	0.0966	CbGeAlD
Carbachol—PLA2G4A—midbrain—Gilles de la Tourette syndrome	0.0322	0.0951	CbGeAlD
Carbachol—CHRNA2—central nervous system—Gilles de la Tourette syndrome	0.0315	0.093	CbGeAlD
Carbachol—PLA2G4A—nervous system—Gilles de la Tourette syndrome	0.0265	0.0782	CbGeAlD
Carbachol—PLA2G4A—central nervous system—Gilles de la Tourette syndrome	0.0255	0.0753	CbGeAlD
Carbachol—CHRNA2—brain—Gilles de la Tourette syndrome	0.025	0.0738	CbGeAlD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0216	0.0327	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0216	0.0326	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0214	0.0323	CbGpPWpGaD
Carbachol—PLA2G4A—brain—Gilles de la Tourette syndrome	0.0203	0.0598	CbGeAlD
Carbachol—CHRM2—nervous system—Gilles de la Tourette syndrome	0.0195	0.0576	CbGeAlD
Carbachol—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.0188	0.0555	CbGeAlD
Carbachol—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0185	0.0279	CbGpPWpGaD
Carbachol—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0184	0.0278	CbGpPWpGaD
Carbachol—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0182	0.0276	CbGpPWpGaD
Carbachol—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0179	0.0271	CbGpPWpGaD
Carbachol—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0179	0.027	CbGpPWpGaD
Carbachol—CHRM1—nervous system—Gilles de la Tourette syndrome	0.0178	0.0524	CbGeAlD
Carbachol—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0177	0.0268	CbGpPWpGaD
Carbachol—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.0171	0.0505	CbGeAlD
Carbachol—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0167	0.0252	CbGpPWpGaD
Carbachol—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0166	0.0252	CbGpPWpGaD
Carbachol—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0165	0.0249	CbGpPWpGaD
Carbachol—CHRM3—nervous system—Gilles de la Tourette syndrome	0.0159	0.0469	CbGeAlD
Carbachol—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0155	0.0235	CbGpPWpGaD
Carbachol—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0155	0.0234	CbGpPWpGaD
Carbachol—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.0153	0.0452	CbGeAlD
Carbachol—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0153	0.0232	CbGpPWpGaD
Carbachol—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0151	0.0228	CbGpPWpGaD
Carbachol—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.015	0.0227	CbGpPWpGaD
Carbachol—CHRM2—brain—Gilles de la Tourette syndrome	0.0149	0.044	CbGeAlD
Carbachol—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0149	0.0225	CbGpPWpGaD
Carbachol—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.014	0.0212	CbGpPWpGaD
Carbachol—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.014	0.0212	CbGpPWpGaD
Carbachol—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0138	0.0209	CbGpPWpGaD
Carbachol—CHRM1—brain—Gilles de la Tourette syndrome	0.0136	0.0401	CbGeAlD
Carbachol—CHRM3—brain—Gilles de la Tourette syndrome	0.0122	0.0359	CbGeAlD
Carbachol—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0117	0.0177	CbGpPWpGaD
Carbachol—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0116	0.0176	CbGpPWpGaD
Carbachol—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0115	0.0175	CbGpPWpGaD
Carbachol—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00982	0.0149	CbGpPWpGaD
Carbachol—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00979	0.0148	CbGpPWpGaD
Carbachol—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0097	0.0147	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00944	0.0143	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00817	0.0124	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00809	0.0122	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00793	0.012	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00785	0.0119	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00723	0.0109	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00517	0.00783	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00512	0.00775	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00435	0.00658	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00422	0.00639	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00393	0.00595	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00379	0.00573	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—HDC—Gilles de la Tourette syndrome	0.00371	0.00561	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00368	0.00556	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00356	0.00539	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00355	0.00537	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00351	0.00532	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00346	0.00523	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00345	0.00521	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00343	0.00518	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00341	0.00516	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00333	0.00504	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00322	0.00487	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00321	0.00486	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00318	0.00481	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00305	0.00462	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00304	0.0046	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00301	0.00456	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00296	0.00448	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00295	0.00447	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00292	0.00442	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00292	0.00441	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00291	0.0044	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00276	0.00417	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00275	0.00416	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00272	0.00412	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00261	0.00395	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0026	0.00394	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00232	0.00351	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00232	0.0035	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00229	0.00347	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00226	0.00341	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00226	0.00341	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00225	0.0034	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00225	0.0034	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00223	0.00337	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00223	0.00337	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00222	0.00336	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0021	0.00318	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00209	0.00317	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00207	0.00314	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00198	0.003	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00193	0.00292	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00193	0.00291	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00193	0.00291	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00191	0.00289	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00179	0.00271	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00147	0.00223	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00147	0.00222	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00145	0.0022	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00131	0.00199	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00131	0.00198	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0013	0.00196	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00127	0.00193	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00127	0.00192	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00126	0.0019	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00126	0.0019	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00119	0.0018	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00119	0.0018	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00119	0.0018	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00118	0.00179	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00118	0.00178	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00117	0.00177	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00117	0.00177	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00116	0.00175	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00115	0.00175	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00114	0.00173	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00114	0.00172	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00108	0.00163	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00107	0.00163	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00106	0.00161	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00106	0.0016	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000832	0.00126	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000829	0.00125	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000821	0.00124	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000755	0.00114	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000753	0.00114	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000745	0.00113	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000742	0.00112	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000704	0.00107	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000702	0.00106	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000695	0.00105	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000684	0.00103	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000682	0.00103	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000675	0.00102	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000637	0.000964	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000635	0.000961	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000629	0.000951	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000446	0.000675	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000445	0.000673	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00044	0.000666	CbGpPWpGaD
